IDXX
Price
$410.93
Change
-$15.32 (-3.59%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
44.84B
26 days until earnings call
RMD
Price
$213.34
Change
-$9.66 (-4.33%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
29.13B
20 days until earnings call
Ad is loading...

IDXX vs RMD

Header iconIDXX vs RMD Comparison
Open Charts IDXX vs RMDBanner chart's image
IDEXX Laboratories
Price$410.93
Change-$15.32 (-3.59%)
Volume$30.52K
Capitalization44.84B
ResMed
Price$213.34
Change-$9.66 (-4.33%)
Volume$5.03K
Capitalization29.13B
IDXX vs RMD Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. RMD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and RMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (IDXX: $426.25 vs. RMD: $223.00)
Brand notoriety: IDXX and RMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 69% vs. RMD: 63%
Market capitalization -- IDXX: $44.84B vs. RMD: $29.13B
IDXX [@Medical Specialties] is valued at $44.84B. RMD’s [@Medical Specialties] market capitalization is $29.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileRMD’s FA Score has 1 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than IDXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 5 TA indicator(s) are bullish while RMD’s TA Score has 5 bullish TA indicator(s).

  • IDXX’s TA Score: 5 bullish, 5 bearish.
  • RMD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RMD is a better buy in the short-term than IDXX.

Price Growth

IDXX (@Medical Specialties) experienced а +2.04% price change this week, while RMD (@Medical Specialties) price change was +0.50% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.32%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

IDXX is expected to report earnings on Apr 30, 2025.

RMD is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Medical Specialties (-4.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than RMD($29.1B). IDXX has higher P/E ratio than RMD: IDXX (52.87) vs RMD (31.34). IDXX YTD gains are higher at: 3.098 vs. RMD (-6.498). RMD has higher annual earnings (EBITDA): 1.43B vs. IDXX (1.22B). IDXX has more cash in the bank: 454M vs. RMD (210M). IDXX has less debt than RMD: IDXX (1.07B) vs RMD (1.39B). RMD has higher revenues than IDXX: RMD (4.5B) vs IDXX (3.66B).
IDXXRMDIDXX / RMD
Capitalization44.8B29.1B154%
EBITDA1.22B1.43B85%
Gain YTD3.098-6.498-48%
P/E Ratio52.8731.34169%
Revenue3.66B4.5B81%
Total Cash454M210M216%
Total Debt1.07B1.39B77%
FUNDAMENTALS RATINGS
IDXX vs RMD: Fundamental Ratings
IDXX
RMD
OUTLOOK RATING
1..100
1710
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
5959
SMR RATING
1..100
1838
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
7667
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for IDXX (84). This means that RMD’s stock grew significantly faster than IDXX’s over the last 12 months.

RMD's Profit vs Risk Rating (59) in the Medical Specialties industry is in the same range as IDXX (59). This means that RMD’s stock grew similarly to IDXX’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is in the same range as RMD (38). This means that IDXX’s stock grew similarly to RMD’s over the last 12 months.

RMD's Price Growth Rating (55) in the Medical Specialties industry is in the same range as IDXX (60). This means that RMD’s stock grew similarly to IDXX’s over the last 12 months.

RMD's P/E Growth Rating (67) in the Medical Specialties industry is in the same range as IDXX (76). This means that RMD’s stock grew similarly to IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXRMD
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
50%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 8 days ago
64%
Declines
ODDS (%)
Bearish Trend 22 days ago
70%
Bearish Trend 14 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
45%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHPT0.620.02
+3.21%
ChargePoint Holdings
SKT34.650.63
+1.85%
Tanger
BBY75.731.36
+1.83%
Best Buy Company
EVAX1.690.03
+1.81%
Evaxion Biotech A/S
VIRC9.38-0.12
-1.26%
Virco Manufacturing Corp

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+1.83%
MYGN - IDXX
48%
Loosely correlated
-0.45%
TFX - IDXX
40%
Loosely correlated
+0.77%
IQV - IDXX
40%
Loosely correlated
+1.83%
SNN - IDXX
40%
Loosely correlated
-0.21%
SONVY - IDXX
40%
Loosely correlated
-1.31%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with OSUR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then OSUR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
-4.33%
OSUR - RMD
36%
Loosely correlated
-4.45%
PODD - RMD
34%
Loosely correlated
-4.48%
OM - RMD
33%
Loosely correlated
-8.89%
ABT - RMD
33%
Poorly correlated
-0.23%
IDXX - RMD
32%
Poorly correlated
-3.63%
More